This is the second time Moon Mother Hemp Company has placed among the top five brands on our ranking. The Colorado-based company, which was founded about a year ago, sets the bar very high for quality (including USDA-certified organic hemp) without charging the moon for its products. Their tinctures taste so good, you may be sad you don’t need more.
Take your skin care routine to lofty new heights with Abinoid Botanicals’ Blue Chamomile and Hemp Face Serum. Infused with 100mg of full-spectrum CBD, this silky smooth serum effortlessly delivers potent anti-inflammatory properties. Boasting 23 beneficial phytonutrients, and some of Mother Nature’s most moisturizing compounds, it puts glowing, radiant skin quite literally at your fingertips.
After two decades of experience in the hemp industry, Paul Benhaim founded Elixinol – ostensibly, as the company’s website states, to “[manufacture] and [provide] the highest-quality CBD oil and hemp extracts in the world.” And so that CBD oil users can be assured of that quality, Elixinol extensively tests its extracts and provides certificates of analysis for its products that are available to view at a click. The manufacturer’s wares have even received a “stamp of approval” from The Realm of Caring Foundation, a Colorado-based non-profit and advocate for cannabinoid therapy research and education. Those wanting to assess Elixinol’s extracts for themselves can choose from its range of oral tinctures – with potencies of 300 mg, 600 mg and 3,600 mg – as well as topical balms and capsules. Plus, the company gives 5 percent of the proceeds from every sale to charity – so buyers may not only feel good after their purchases, but they’ll do some good, too.
The Texas Controlled Substances Act is codified under Texas Health and Safety Code Chapter 481. Health and Safety Code Section 481.032 says that the Commissioner of State Health Services is to set out what substances are deemed Controlled Substances in Texas under Schedules I through V. Chapter 481.034 retains the right for the legislature to remove substances from the Controlled Substance list.
Generalized pain, for instance, has dozens upon dozens of high profile research and clinical studies that have been carried out in universities and laboratories around the globe. One of the most well-publicized of these studies took place back in 2008, in which results determined that “cannabinoid analgesics (pain relievers) have generally been well tolerated in clinical trials … with acceptable adverse event profiles (meaning acceptable effectiveness for practical use).